After the second dose of the homologous vaccination scheme, more serum samples tested positive for ADE of infection dependent on the CD89 receptor than for ADE of infection dependent on CD16, suggesting that IgA in the serum may enhance infection with the Omicron variant (Figure 2). Here, FCGR3A is linked to infection.